CIA
Capital Impact Advisors Portfolio holdings
AUM
$332M
This Quarter Return
+12.77%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$81.5M
AUM Growth
+$81.5M
(-20%)
Cap. Flow
-$26.8M
Cap. Flow
% of AUM
-32.83%
Top 10 Holdings %
Top 10 Hldgs %
12.33%
Holding
250
New
14
Increased
52
Reduced
65
Closed
73
Top Buys
| 1 |
Alkermes
ALKS
|
$732K |
| 2 |
Pegasystems
PEGA
|
$549K |
| 3 |
Kinder Morgan
KMI
|
$521K |
| 4 |
Devon Energy
DVN
|
$514K |
| 5 |
Signet Jewelers
SIG
|
$502K |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.2M |
| 2 |
Apple
AAPL
|
$1.1M |
| 3 |
Microsoft
MSFT
|
$1.01M |
| 4 |
NVIDIA
NVDA
|
$996K |
| 5 |
Clean Harbors
CLH
|
$811K |
Sector Composition
| 1 | Healthcare | 31.42% |
| 2 | Technology | 24.96% |
| 3 | Consumer Discretionary | 12.02% |
| 4 | Industrials | 9.82% |
| 5 | Financials | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Globus Medical
GMED
$7.94B
| $380K | 0.47% |
6,713
-11,172
| -62% | -$633K |
|
102
Trupanion
TRUP
$1.9B
| $379K | 0.46% |
8,832
| – | – |
|
103
Arcus Biosciences
RCUS
$1.24B
| $374K | 0.46% |
20,501
+4,344
| +27% | +$79.2K |
|
104
Relay Therapeutics
RLAY
$709M
| $372K | 0.46% |
22,612
+6,184
| +38% | +$102K |
|
105
10x Genomics
TXG
$1.66B
| $371K | 0.46% |
6,655
+3,879
| +140% | +$216K |
|
106
CRISPR Therapeutics
CRSP
$4.82B
| $371K | 0.46% |
+8,205
| New | +$371K |
|
107
Acadia Pharmaceuticals
ACAD
$4.34B
| $365K | 0.45% |
19,372
+1,160
| +6% | +$21.8K |
|
108
Arvinas
ARVN
$580M
| $364K | 0.45% |
13,319
+5,280
| +66% | +$144K |
|
109
Cerus
CERS
$251M
| $359K | 0.44% |
120,915
+8,081
| +7% | +$24K |
|
110
Forrester Research
FORR
$184M
| $355K | 0.44% |
10,980
-6,297
| -36% | -$204K |
|
111
Castle Biosciences
CSTL
$673M
| $351K | 0.43% |
15,452
| – | – |
|
112
CarGurus
CARG
$3.51B
| $343K | 0.42% |
18,342
| – | – |
|
113
Natera
NTRA
$23B
| $341K | 0.42% |
+6,135
| New | +$341K |
|
114
Arhaus
ARHS
$1.57B
| $337K | 0.41% |
40,616
-34,209
| -46% | -$284K |
|
|
AMED
115
DELISTED
Amedisys
AMED
| $332K | 0.41% |
4,515
-2,261
| -33% | -$166K |
|
116
Exact Sciences
EXAS
$9.33B
| $330K | 0.4% |
4,867
-1,609
| -25% | -$109K |
|
117
IMAX
IMAX
$1.57B
| $326K | 0.4% |
17,018
| – | – |
|
118
Compass
COMP
$4.76B
| $326K | 0.4% |
+100,978
| New | +$326K |
|
119
J&J Snack Foods
JJSF
$2.12B
| $326K | 0.4% |
2,198
-1,465
| -40% | -$217K |
|
|
FNA
120
DELISTED
Paragon 28, Inc.
FNA
| $319K | 0.39% |
18,701
+1,352
| +8% | +$23.1K |
|
121
Alector
ALEC
$282M
| $319K | 0.39% |
51,465
-17,162
| -25% | -$106K |
|
122
Cinemark Holdings
CNK
$2.92B
| $316K | 0.39% |
21,377
| – | – |
|
123
Repay Holdings
RPAY
$482M
| $311K | 0.38% |
47,347
+19,380
| +69% | +$127K |
|
124
Teladoc Health
TDOC
$1.37B
| $309K | 0.38% |
11,912
+1,973
| +20% | +$51.1K |
|
125
Pinnacle Financial Partners
PNFP
$7.56B
| $306K | 0.38% |
5,556
| – | – |
|